Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Hemangioma natural history, complications and prognosis
Introduction
Overview
Overview
If left untreated, 20% of patients with hemangioma may progress to develop ulceration, hemorrhage, infection, and high output cardiac failure. Common complications of hemangioma include ischemia, necrosis, ulceration, and bleeding. Prognosis is generally good.
Natural history
Natural history
Hemangiomas are vascular tumors that are rarely apparent at birth, grow rapidly during the first six months of life, involute with time and do not necessarily infiltrate but can sometimes be destructive.[1][2]
Complications
Complications
Rapid growth of hemangiomas can lead to exhaustion of blood supply with resulting:[1]
Ophthalmic complications
Common complications of infantile hemangioma include:[3]
- Amblyopia
- Strabismus
- Proptosis
- Exposure keratopathy
- Compressive optic neuropathy
Prognosis
Prognosis
Hemangioma generally has a good prognosis and is cosidered as a benign condition.
References
References
- ↑ 1.0 1.1 Richter, Gresham T.; Friedman, Adva B. (2012). “Hemangiomas and Vascular Malformations: Current Theory and Management”. International Journal of Pediatrics. 2012: 1–10. doi:10.1155/2012/645678. ISSN 1687-9740.
- ↑ Hassan, Basheir A.; Shreef, Khalid S. (2014). “Propranolol in Treatment of Huge and Complicated Infantile Hemangiomas in Egyptian Children”. Dermatology Research and Practice. 2014: 1–5. doi:10.1155/2014/541810. ISSN 1687-6105.
- ↑ Callahan, Alison B.; Yoon, Michael K. (2012). “Infantile hemangiomas: A review”. Saudi Journal of Ophthalmology. 26 (3): 283–291. doi:10.1016/j.sjopt.2012.05.004. ISSN 1319-4534.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1];Associate Editor(s)-in-Chief: Nawal Muazam M.D.[2]